Symptoms of CRS may include:
Get medical help right away if you develop any signs or symptoms of CRS at any time.
Most CRS events occurred during the first cycle of treatment. CRS occurred in 39% of patients (86 of 218 patients).
CRS was generally managed with appropriate treatment in the clinical trial. CRS should be managed by your healthcare team
Do not drive, operate heavy machinery, or do other dangerous activities if you develop dizziness, confusion, tremors, sleepiness, or any other symptoms that impair consciousness until your signs and symptoms go away. These may be signs and symptoms of CRS or neurologic problems
Carry your LUNSUMIO Patient Wallet Card with you at all times and show it to your doctors. This card lists the signs and symptoms of CRS and other important information. You can download your wallet card below.
The most common side effects of LUNSUMIO include:
The most common severe abnormal lab test results with LUNSUMIO include:
These are not all the possible side effects of LUNSUMIO.
Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Preparing for treatment with LUNSUMIO
Talking to your doctor about LUNSUMIO
Getting support during treatment with LUNSUMIO
A type of white blood cell that makes antibodies. B cells are part of the immune system and develop from stem cells in the bone marrow. FL is a type of B-cell lymphoma.
Bispecific antibodies are designed to target 2 different sites on different cells or the same cell. For example, a bispecific antibody binding to 2 different cells is thought to bring the cells together, such as an immune cell and cancer cell.
The soft spongy material that fills the inside of bones. Bone marrow is the source of new blood cells, and platelets are made in the bone marrow.
Also called complete response—the disappearance of all signs of cancer in response to treatment. This does not mean the cancer has been cured.
A side effect where your immune system responds too strongly by rapidly releasing a large amount of substances known as cytokines. It may cause fever, nausea, or other symptoms.
A period of treatment followed by a period of rest (no treatment) that is repeated on a regular schedule.
The most common type of indolent (slow-growing) non-Hodgkin lymphoma (NHL). With NHL, abnormal lymphocytes (white blood cells) build up in the lymph nodes, bone marrow, and spleen. FL develops when the body makes abnormal B lymphocytes, making it a type of B-cell lymphoma. FL can be a chronic disease.
Small bean-shaped organs that store white blood cells.
A type of cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system. FL is a type of non-Hodgkin lymphoma.
A partial or complete remission.
Also called partial response—some measurable decrease in size of the cancer.
A type of clinical trial that studies an investigational treatment to test how well it works and monitors for potential side effects.
A term used to describe disease that has not responded to previous treatment.
A term used to describe disease that has returned after responding to previous treatment.
A term used to describe a response to treatment.
An organ that is part of the lymphatic system. The spleen makes lymphocytes (white blood cells), filters blood, stores blood cells, and destroys old blood cells. It is located on the left side of the abdomen near the stomach.
A smaller dose of LUNSUMIO that you receive on Day 1 and Day 8 of your first cycle of treatment.
A type of white blood cell. T cells are part of the immune system, helping to protect the body from infection and may also help fight cancer. A subset, cytotoxic T cells, bind to and kill infected cells and cancer cells.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.